ASPEN PHARMACARE HOLDINGS LIMITED - Director's Dealings

Director's Dealings

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen" or "the Company")


DEALING IN SECURITIES BY DIRECTORS AND BY DIRECTORS OF A MAJOR
SUBSIDIARY
In compliance with paragraph 3.63 of the Listings Requirements of the
JSE Limited, disclosure is made of the following information:

Deferred bonus shares, awarded in terms of the Aspen SA Management
Deferred Incentive Bonus Scheme and accepted by directors and
directors of major subsidiaries in 2009, have vested and are available
for release. Directors and directors of major subsidiaries have
accepted the release of these deferred bonus shares as follows:

BY DIRECTORS OF THE COMPANY:

Director                          :   Michael Guy Attridge
Company                           :   Aspen Pharmacare Holdings Limited
Date of transaction               :   21 November 2012
Number of shares to be released   :   23 938
Class of securities               :   Ordinary shares
Nature of interest                :   Direct beneficial
Clearance obtained                :   Yes

Director                          :   Stephen Bradley Saad
Company                           :   Aspen Pharmacare Holdings Limited
Date of transaction               :   21 November 2012
Number of shares to be released   :   28 958
Class of securities               :   Ordinary shares
Nature of interest                :   Direct beneficial
Clearance obtained                :   Yes

BY DIRECTORS OF A MAJOR SUBSIDIARY:

Director                          :   Sean Matthew Capazorio
Company                           :   Pharmacare Limited
Date of transaction               :   21 November 2012
Number of shares to be released   :   8 058
Class of securities               :   Ordinary shares
Nature of interest                :   Direct beneficial
Clearance obtained                :   Yes

Director                          :   Mziwandile Noel Guliwe
Company                           :   Pharmacare Limited
Date of transaction               :   21 November 2012
Number of shares delivered        :   5 672
Class of securities               :   Ordinary shares
Nature of interest                :   Direct beneficial
Clearance obtained                :   Yes
All releases of Deferred Incentive Bonus shares are deemed to be off-
market trades.

Durban
23 November 2012

Sponsor
Investec Bank Limited

Date: 23/11/2012 10:06:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.